Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U74900MH2014PTC254786 Incorporated 21 March 2014 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹117.77 Cr
▲ 26% YoY
Net profit · FY 2025
₹10.21 Cr
Net margin 8.7%
EBITDA · FY 2025
₹14.78 Cr
EBITDA margin 12.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹92.85 Lakh
Issued & subscribed
Open charges
₹65 Cr
Satisfied ₹15.72 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
33
Provident fund records

About Bioaltus Pharmaceuticals Private Limited

Data last updated:

Bioaltus Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC254786. Its GSTIN is 27AAFCB8840D1ZQ (Maharashtra). The company holds 5 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹92.85 Lakh. It is led by directors Ankit Varshney (Whole-Time Director) and Gopinath Ramankutty Nair (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹117.77 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹10.21 Cr (net margin 8.7%) and EBITDA of ₹14.78 Cr (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 17% over five years.

The company has about 33 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Bioaltus. As per MCA filings, the company has open charges of ₹65 Cr and satisfied charges of ₹15.72 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company; 1 case is pending. The company has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is M J Biopharm Private Limited with revenue of ₹119.1 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 3,547 overdue payments to 91 micro and small suppliers.

Bioaltus Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0046060). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioaltus.com.

Company Details of Bioaltus Pharmaceuticals Private Limited
CIN U74900MH2014PTC254786
Registration Number 254786
Incorporation Date 21 March 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0046060
Key People
Ankit Varshney Whole-Time Director Gopinath Ramankutty Nair Whole-Time Director

Recognitions & Rankings of Bioaltus Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-33-0046060
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    bioaltus.com
  • Social Media
  • Registered Address
    First Floor Office No. 25 – 28 Tl 5 Morning Glory Tropical Lagoon Phase III Kavesar Ghodb, Under Road, Thane, Maharashtra, India – 400615
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Bioaltus Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Bioaltus Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Bioaltus Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals operates one associated brand: Bioaltus. Each brand links to its own profile.

BrandDescriptionWebsite
Bioaltus
Provides contract manufacturing and pharmaceutical products for medical fields like diabetology and cardiology.bioaltus.com

Business Activity of Bioaltus Pharmaceuticals Private Limited

The main business activity of Bioaltus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Bioaltus Pharmaceuticals Private Limited FY 2025 filings available

Bioaltus Pharmaceuticals Private Limited reported revenue of ₹117.77 Cr (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹117.77 Cr ▲ 26%
Net profit · FY 2025
₹10.21 Cr margin 8.7%
EBITDA · FY 2025
₹14.78 Cr margin 12.5%

Compounded Annual Growth Rate (CAGR) of Bioaltus Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 14%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 79%
5 years · compounded
▲ 32%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 26% growth in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Bioaltus Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹14.78 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹10.21 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Bioaltus Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.5%••••••••••••••••
Net Profit Margin8.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bioaltus Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ankit Varshney
Also directs: Bioaltus Lifesciences Private Limited
Whole-Time Director21 Mar 201412 Years 7 MonthsCurrent
Gopinath Ramankutty Nair
Also directs: Bioaltus Lifesciences Private Limited
Whole-Time Director18 Aug 201412 Years 2 MonthsCurrent
View all directors

Peer Comparison of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
M J Biopharm Private Limited₹119.1 Cr (FY 2017)••••••••9.0%••••Mumbai, Maharashtra, India
Pell Tech Health Care Private Limited₹118.72 Cr (FY 2025)••••••••16.0%••••Thane, Maharashtra, India
Ronak Healthcare Private Limited₹118.43 Cr (FY 2025)••••••••79.0%••••Vadodara, Gujarat, India
Zen Pharma Private Limited₹118.25 Cr (FY 2022)••••••••24.0%••••Mumbai, Maharashtra, India
Anglo-French Drugs & Industries Limited₹117.99 Cr (FY 2025)••••••••18.0%••••Mumbai, Maharashtra, India
Bioaltus Pharmaceuticals Private Limited this company₹117.77 Cr (FY 2025)••••••••26.0%••••Thane, Maharashtra, India
Westcoast Pharmaceutical Works Limited₹117.56 Cr (FY 2024)••••••••-3.0%••••Ahmedabad, Gujarat, India
Flagship Biotech International Private Limited₹117.23 Cr (FY 2025)••••••••22.0%••••Navi Mumbai, Maharashtra, India
Crius Life Sciences Private Limited₹116.77 Cr (FY 2025)••••••••3.0%••••Nalagarh, Himachal Pradesh, India
Kerala State Drugs and Pharmaceuticals Ltd₹116.23 Cr (FY 2024)••••••••41.0%••••Alappuzha, Kerala, India
Ar-Ex Laboratories Private Limited₹115.46 Cr (FY 2025)••••••••16.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Bioaltus Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited is audited by S A H A G & ASSOCIATES for the financial year 2024.

NameStatusAppointment DateCessation Date
S A H A G & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Bioaltus Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Bioaltus Pharmaceuticals Private Limited

Open charges
₹65 Cr
Satisfied charges
₹15.72 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹65.00 Cr
Latest charge details
DateLenderAmountStatus
15 May 2025Hdfc Bank Limited₹65 CrOpen
31 Dec 2022State Bank of India₹7.5 CrSatisfied
13 Jan 2022Others₹49.98 LakhSatisfied
19 May 2020Others₹4 CrSatisfied
28 Sep 2018Others₹3 CrSatisfied

Total charge records: 7 View all charges

Deals & Funding of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021.

Total deals
6
Rights issues
2
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹7.77 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Dec 2021Funding round₹7.48 CrInvestors: an individual
Jan 2021Rights issue₹15 LakhInvestors: 4 individuals
Jul 2019Rights issue₹15 LakhInvestors: 2 individuals
Nov 2018Funding round₹29 LakhInvestors: 3 individuals
Mar 2016Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 3,547 overdue payments to 91 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 91)

SupplierAmount dueDue sinceReported on
Base Foils••••••••••••
D M Pharma••••••••••••
an individual supplier••••••••••••
an individual supplier••••••••••••
Mediraw Pharma & Nutra Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited has a workforce of 33 employees as of Mar 31, 2025.

Employee count
33
Active EPFO establishments
1
Employee growth
17.86%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Bioaltus Lifesciences Private LimitedU21001MH2023PTC407189Locked

Showing major subsidiaries. Total: 1.

Recent Activity on Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals Private Limited has 8 board changes on record since 2014: 2 appointments and 6 cessations. The latest: Devanshi Vijay Doshi ceased to be Additional Director on 30 Sep 2022.

AGM
Bioaltus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 65.00 Cr registered on 15 May 2025 with Charge ID 101107796 was modified on 08 Jul 2025.
Charges
A charge registered on 31 Dec 2022 via Charge ID 100673869 with State Bank Of India was fully satisfied on 20 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 65.00 Cr with Charge ID 101107796 was registered on 15 May 2025.
Filing
Bioaltus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 100673869 was registered on 31 Dec 2022.
Charges
A charge registered on 13 Jan 2022 via Charge ID 100532554 with Others was fully satisfied on 14 Oct 2022.
Ceased
Devanshi Vijay Doshi ceased to be Additional Director.
Ceased
Mehul Pravin Shah ceased to be Director.
Charges
A charge registered on 19 May 2020 via Charge ID 100337501 with Others was fully satisfied on 12 Aug 2022.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100532554 was registered on 13 Jan 2022.
Charges
A charge registered on 28 Sep 2018 via Charge ID 100217713 with Others was fully satisfied on 27 May 2021.

13 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Bioaltus Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Bioaltus Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.

Total GSTINs
5
Active
5
GSTINStateStatusRegistered on
27AAFCB8840D1ZQMaharashtraActive01 Jul 2017
02AAFCB8840D1Z2Himachal PradeshActive01 Jul 2017
11AAFCB8840D1Z3SikkimActive24 Nov 2020
05AAFCB8840D1ZWUttarakhandActive20 Mar 2024
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Bioaltus Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bioaltus Pharmaceuticals Private Limited

Bioaltus Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2014 (12+ years old) and is registered under CIN U74900MH2014PTC254786.

Bioaltus Pharmaceuticals reported revenue of ₹117.77 Cr for FY 2025 (up 26% YoY).

Bioaltus Pharmaceuticals has 2 current directors:

Bioaltus Pharmaceuticals reported a net profit of ₹10.21 Cr (net margin 8.7%) and EBITDA of ₹14.78 Cr (EBITDA margin 12.5%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Bioaltus Pharmaceuticals is 14% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Bioaltus Pharmaceuticals is 27AAFCB8840D1ZQ, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 02AAFCB8840D1Z2 (Himachal Pradesh), 11AAFCB8840D1Z3 (Sikkim), 05AAFCB8840D1ZW (Uttarakhand).

The CIN (Corporate Identification Number) of Bioaltus Pharmaceuticals is U74900MH2014PTC254786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bioaltus Pharmaceuticals has 5 court cases on record: 3 filed by the company. 1 is pending. Most are in the district courts.

Bioaltus Pharmaceuticals was incorporated on 21 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

Bioaltus Pharmaceuticals has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021.

The peers of Bioaltus Pharmaceuticals by revenue are M J Biopharm Private Limited, Pell Tech Health Care Private Limited, Ronak Healthcare Private Limited, Zen Pharma Private Limited, Anglo-French Drugs & Industries Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Devanshi Vijay Doshi ceased to be Additional Director on 30 Sep 2022. Mehul Pravin Shah ceased to be Director on 25 Aug 2022. Ankit Varshney ceased to be Director on 06 Jan 2016. Bioaltus Pharmaceuticals has 8 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available